Correlation Engine 2.0
Clear Search sequence regions

  • calcium (5)
  • humans (1)
  • hypercalcemia (7)
  • lithium (1)
  • patients (1)
  • vitamin d (4)
  • Sizes of these terms reflect their relevance to your search.

    This review focuses on the commonly prescribed medicaments that can be responsible for hypercalcemia, considering the prevalence, the predominant pathophysiological mechanisms, and the optimal medical management of each drug-induced hypercalcemia. Vitamin D supplements and 1α-hydroxylated vitamin D analogues increase intestinal calcium absorption, renal calcium reabsorption as well as bone resorption. In patients with hypoparathyroidism receiving recombinant human PTH, transient hypercalcemia can occur because of overtreatment, usually during acute illness. Thiazide-induced hypercalcemia is mainly explained by enhanced renal proximal calcium reabsorption, changing preexistent asymptomatic normocalcemic or intermittently hypercalcemic hyperparathyroidism into the classic hypercalcemic hyperparathyroidism. Lithium causes hypercalcemia mainly by drug-induced hyperparathyroidism. Copyright © 2021 Elsevier Inc. All rights reserved.


    Anne-Lise Lecoq, Marine Livrozet, Anne Blanchard, Peter Kamenický. Drug-Related Hypercalcemia. Endocrinology and metabolism clinics of North America. 2021 Dec;50(4):743-752

    Expand section icon Mesh Tags

    Expand section icon Substances

    PMID: 34774245

    View Full Text